Bajaj HealthCare Limited (NSE:BAJAJHCARE)
India · Delayed Price · Currency is INR 311.15
-0.55 (-0.18%)
Apr 2, 2026, 3:29 PM IST
Bajaj HealthCare Market Cap
Bajaj HealthCare has a market cap or net worth of 9.82 billion as of April 2, 2026. Its market cap has decreased by -50.72% in one year.
Market Cap
9.82B
Enterprise Value
12.06B
Revenue
6.12B
Ranking
n/a
PE Ratio
19.73
Stock Price
311.15
Market Cap Chart
Since May 10, 2016, Bajaj HealthCare's market cap has increased from 1.16B to 9.82B, an increase of 748.63%. That is a compound annual growth rate of 24.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 9.82B | -25.09% |
| Dec 31, 2025 | 13.11B | -27.72% |
| Dec 31, 2024 | 18.14B | 74.95% |
| Dec 29, 2023 | 10.37B | -15.46% |
| Dec 30, 2022 | 12.27B | 7.73% |
| Dec 31, 2021 | 11.39B | 85.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 30.72B |
| Orchid Pharma | 24.47B |
| Solara Active Pharma Sciences | 20.50B |
| Windlas Biotech | 15.53B |
| Indoco Remedies | 15.14B |
| Jagsonpal Pharmaceuticals | 12.32B |
| Beta Drugs | 12.01B |
| Ind-Swift Laboratories | 11.40B |